On the other hand, cytotoxic T lymphocytes (CTLs) require precise ROS regulation when delivering cytotoxic particles through immune synapses (45), so the expression of GPX2 in T cells or ROS levels in the tumor microenvironment may directly affect the killing efficiency of CTLs. The gene discussed is GPX2; the disease is neoplasm.